G蛋白结合受体GPR182通过调节CXCL12-CXCR4轴信号传导来负面调节发芽血管生成
Changsheng Chen1, Wei Liu2,3,4, Fang Yuan5,6
1School of Life Sciences, Nantong Laboratory of Development and Diseases, Nantong University, Seyuan Road 9, Nantong, Jiangsu Province, 226019, China. c.chen@ntu.edu.cn.
Angiogenesis
|May 2, 2025
概括
GPR182通过结合CXCL12.2来负面调节瘤血管生成. 其缺乏促进瘤生长,这表明GPR182是新型抗血管原性癌症治疗的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 血管新生对于瘤进展至关重要,但抗血管新生疗法显示出不同的疗效.
- 内皮细胞受体GPR182在瘤中下调,但其在血管生成中的作用尚不清楚.
- 肝细胞癌 (HCC) 经常表现为减少GPR182和增加血管性.
研究的目的:
- 确定GPR182在血管生成和瘤进展中的作用.
- 为了研究GPR182介导血管生成调节的基础分子机制.
- 探索GPR182作为癌症治疗的潜在治疗标.
主要方法:
- 评估了HCC中的GPR182表达,并与CD31相关联.
- 利用斑马鱼模型 (胚胎和HCC) 研究Gpr182缺乏对血管生成的影响.
- 检查了GPR182缺乏的人静脉内皮细胞 (HUVEC) 的行为.
- 研究了GPR182与CXCL12和CXCR4信号的分子相互作用.
- 测试了CXCR4阻断 (AMD3100) 在纠正血管新生缺陷方面的疗效.
主要成果:
- 在HCC中,GPR182表达与CD31相反相关.
- 斑马鱼的Gpr182缺乏导致血管生成和血管增强.
- 缺乏GPR182的HUVEC表现出增加的迁移和扩散.
- GPR182作为CXCL12的诱受体,抑制CXCR4介导的血管生成.
- 在缺乏Gpr182的模型中,AMD3100治疗逆转了异常血管生成.
结论:
- GPR182是一种新型的血管生成负调节剂.
- 缺乏GPR182可促进瘤血管化和生长.
- 准GPR182或其下游途径为癌症治疗提供了潜在的新型抗血管原策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Mechanism of Angiogenesis
5.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K


